Fisetin study to reduce frailty and inflammation in older women
Treatments studied
Part of Immune system & allergy clinical trials.
This Phase 2 trial tests whether fisetin, a supplement, can reduce frailty and inflammation in postmenopausal women age 70 and older. If it works, it may help older adults feel stronger and have healthier body signals related to aging and inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy postmenopausal woman aged 70 or older
- Recent blood/urine tests must be normal (no concerning liver or kidney results)
- You do not have cancer, Crohn’s disease, or hormone problems like thyroid or pituitary disorders
- You are not taking certain medicines that affect bones, hormones, or “cell aging” (senolytic/chemotherapy drugs)
- You have not had a fracture in the past year
- You can take the study medicine by mouth and safely stay off certain medicines for about 2 days when needed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether fisetin, a supplement-like drug, can reduce frailty and inflammation in people age 70 and older. It may help improve health measures related to aging, but you must meet several safety and medication rules to join.
This trial tests whether combining gentle exercise with a special anti-inflammatory drink can help older adults who feel weak and have trouble eating enough. If you are 75 or older and have been told you are frail and malnourished, this study may offer a safe way to improve strength and weight.
This study tests whether a natural supplement called fisetin can help people age more healthily. It is for Danish-speaking adults aged 50 and older who are not taking certain other supplements or medications.
This trial tests a pill called fisetin, which may help clear aging cells from the body. It is studying two groups: healthy younger adults and older adults with multiple health problems who have recently been in the hospital.
This study tests whether adding a supplement called fisetin to an exercise program can help prevent frailty in women who have finished chemotherapy for early-stage breast cancer. If you are postmenopausal, have completed chemo within the last year, and can walk a certain distance, you may qualify.
This study tests whether fisetin (a natural compound) can improve physical function, like walking ability, in breast cancer survivors who feel frail. It may help strengthen muscles and improve daily activity after treatment.
Hear when a new Frail Elderly Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.